Cannabis Shares Underperform Going Into Year-End Amid U.S. Regulatory Logjam

The Botanicals Podcast

Dec 17 2021 | 00:13:40

00:00 / 00:13:40

Show Notes

Although adult-use sales of cannabis remain robust in U.S. states where it is legal, Nasdaq IR Intelligence analyst Saleem Daya sees continued stock underperformance across the Cannabis space going into year-end, building on activity in the second and third quarters of 2021.

Other Episodes

Episode 2

May 28, 2020 • 00:09:32

State Rep. Kelly Cassidy: Illinois Legislators Take Notice of Strong Cannabis Revenues

By Suzanne Cosgrove | May 28, 2020John Lothian News caught up with Illinois State Rep. Kelly Cassidy (D-Chicago) on Wednesday, May 27, just days...

Episode 0

July 21, 2021 • 00:20:20

Cannabis shares pull back in Q2 as U.S. regulatory momentum fizzles

Nasdaq IR Intelligence analyst Saleem Daya explains why the sector's heated year-end performance has cooled; cites rising yields, retail investor fatigue as action on...

Episode 0

January 12, 2021 • 00:20:25

Cannabis Shares Pick Up Pace As 2021 Regulatory Momentum Eyed

Saleem Daya, an analyst with Nasdaq IR Intelligence in Toronto, sees U.S. cannabis regulation poised for a rehaul in 2021 given Democrats' U.S. Senate...